TH糖蛋白抗體 返回列表頁(yè)

TH糖蛋白抗體

英文名稱 Uromodulin
中文名稱 TH糖蛋白抗體
別    名 ADMCKD2; FJHN; HNFJ; HNFJ1; MCKD2; medullary cystic kidney disease 2 (autosomal dominant); Tamm Horsfall glycoprotein; Tamm Horsfall urinary glycoprotein; Tamm-Horsfall urinary glycoprotein; THGP; THP; Umod; UROM_HUMAN; Uromodulin.
   
說(shuō) 明 書(shū) 0.2ml  
研究領(lǐng)域 細(xì)胞生物  免疫學(xué)  
抗體來(lái)源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Pig, Cow, Horse, Sheep, 
產(chǎn)品應(yīng)用 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復(fù)） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 61/64kDa
細(xì)胞定位 細(xì)胞膜 分泌型蛋白 
性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human Uromodulin (405-455aa)
亞    型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

PubMed PubMed
產(chǎn)品介紹 background:
May play a role in regulating the circulating activity of cytokines as it binds to IL-1, IL-2 and TNF with high affinity.
Tissue specificity:Synthesized by kidney. Most abundant protein in normal human urine.
Involvement in disease:Defects in UMOD are the cause of familial juvenile hyperuricemic nephropathy type 1 (HNFJ1) . HNFJ1 is a renal disease characterized by juvenil onset of hyperuricemia, polyuria, progressive renal failure, and gout. The disease is associated with interstitial pathological changes resulting in fibrosis.
Defects in UMOD are the cause of medullary cystic kidney disease type 2 (MCKD2) [MIM:603860]. MCKD2 is a form of tubulointerstitial nephropathy characterized by formation of renal cysts at the corticomedullary junction. It is characterized by adult onset of impaired renal function and salt wasting resulting in end-stage renal failure by the sixth decade. his gene encodes uromodulin, the most abundant protein innormal urine. Its excretion in urine follows proteolytic cleavageof the ectodomain of its glycosyl phosphatidylinosital-anchoredcounterpart that is situated on the luminal cell surface of theloop of Henle. Uromodulin may act as a constitutive inhibitor ofcalcium crystallization in renal fluids. Excretion of uromodulin inurine may provide defense against urinary tract infections causedby uropathogenic bacteria. Defects in this gene are associated withthe autosomal dominant renal disorders medullary cystic kidneydisease-2 (MCKD2) and familial juvenile hyperuricemic nephropathy(FJHN). These disorders are characterized by juvenile onset ofhyperuricemia, gout, and progressive renal failure. While severaltranscript variants may exist for this gene, the full-lengthnatures of only two have been described to date. These tworepresent the major variants of this gene and encode the sameisoform. 

Function:
Uromodulin: Functions in biogenesis and organization ofthe apical membrane of epithelial cells of the thick ascending limbof Henle's loop (TALH), where it promotes formation of complexfilamentous gel-like structure providing the water barrierpermeability. May serve as a receptor for binding and endocytosisfor cytokines (IL-1, IL-2) and TNF. Facilitates neutrophilmigration across renal epithelial.
Uromodulin, secreted form: Secreted into urine afterproteolytically cleaveage. Into the urine, may contribute tocolloid osmotic pressure, retards passage of positively chargedelectrolytes, prevents urinary tract infection and modulatesformation of supersaturated salts and their crystals. 

Subcellular Location:
Apical cell membrane; Lipid-anchor,GPI-anchor. Basolateral cell membrane; Lipid-anchor, GPI-anchor.Cell projection, cilium membrane. Note=Only a small fraction issort to the basolateral pole of tubular epithelial cells comparedto apical localization. Secreted into urine after cleavage.Colocalized with NPHP1 and KIF3A.
Uromodulin, secreted form: Secreted. 

Tissue Specificity:
Synthesized exclusively in the kidney.Expressed exclusively by epithelial cells of the thick ascendinglimb of Henle's loop (TALH) and of distal convoluted tubule lumen.Most abundant protein in normal urine.

Post-translational modifications:
N-glycosylated. N-glycan heterogeneity at Asn-232:Hex7HexNAc6 (major) and dHex1Hex7HexNAc6 (minor); at Asn-322:dHex1Hex6HexNAc5 (minor), dHex1Hex7HexNAc6 (major) anddHex1Hex8HexNAc7 (minor); at Asn-396: Hex6HexNAc5 (major),dHex1Hex6HexNAc5 (minor) and Hex7HexNAc6 (minor).
Proteolytically cleaved at a conserved C-terminal proteolyticcleavage site to generate the secreted form found into urine. 

DISEASE:
Defects in UMOD are the cause of familial juvenilehyperuricemic nephropathy type 1 (HNFJ1) [MIM:162000]. HNFJ1 is arenal disease characterized by juvenil onset of hyperuricemia,polyuria, progressive renal failure, and gout. The disease isassociated with interstitial pathological changes resulting infibrosis.
Defects in UMOD are the cause of medullary cystic kidneydisease type 2 (MCKD2) [MIM:603860]. MCKD2 is a form oftubulointerstitial nephropathy characterized by formation of renalcysts at the corticomedullary junction. It is characterized byadult onset of impaired renal function and salt wasting resultingin end-stage renal failure by the sixth decade.
Defects in UMOD are the cause of glomerulocystic kidneydisease with hyperuricemia and isosthenuria (GCKDHI) [MIM:609886].GCKDHI is a renal disorder characterized by a cystic dilation ofBowman space, a collapse of glomerular tuft, and hyperuricemia dueto low fractional excretion of uric acid and severe impairment ofurine concentrating ability. 

Similarity:
Contains 3 EGF-like domains.
Contains 1 ZP domain. 

Database links:
UniProtKB/Swiss-Prot: P07911.1

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.xy-5561R    phospho-PRKD1(Ser738)磷酸化蛋白激酶C mu型抗體
xy-5563R    phospho-PRKD1(Tyr463)磷酸化蛋白激酶C mu型抗體
xy-2690R    PILR beta細(xì)胞表面受體PILRβ抗體
xy-7002R    PAGE4前列腺癌相關(guān)蛋白4抗體
xy-7003R    PMPCB線粒體導(dǎo)肽水解酶β抗體
xy-9408R    PRR15富含脯氨酸蛋白15抗體
xy-10486R    protein C light chain維生素K依賴的蛋白C輕鏈抗體
xy-10487R    protein C Activation peptide
xy-0686R    PTEN一種腫瘤抑制基因抗體（C端）
xy-1478R    PAFR血小板活化因子受體抗體
xy-5422R    PP1C gamma蛋白磷酸酶γ1抗體
xy-4181R    p53R2核苷酸還原酶M2B抗體
xy-2384R    PDE4A磷酸二酯酶4A抗體
xy-3643R    PLASTIN3絲束蛋白T Plastin抗體
xy-3638R    Plexin A2神經(jīng)叢蛋白A2抗體
xy-3640R    Plectin網(wǎng)蛋白抗體
xy-10171R    PTOV1前列腺腫瘤高表達(dá)蛋白1抗體
xy-5596R    phospho-P53(Thr55)磷酸化腫瘤抑制基因P53抗體
xy-4180R    P2Y2嘌呤ATP受體抗體
xy-2210R    phospho-p38 MAPK (Thr180 + Tyr182)磷酸化絲裂原活化蛋白激酶p38抗體
xy-2219R    Pectinesterase inhibitor 18果膠酶抑制蛋白18抗體
xy-3614R    PPAR alphaα型-過(guò)氧化酶活化增生受體抗體（PPAR α, PPAR-α）
xy-2561R    PSGD/HOXB13同源盒蛋白HOXB13抗體
xy-5537R    Phospho-PDPK1(Ser393)磷酸化3磷酸肌醇依賴性蛋白激酶1抗體
xy-3716R    Phospho-p63 (Ser160+Ser162)磷酸化P63腫瘤抑制基因抗體
xy-2270R    Phospho-PAK4(Ser99)磷酸化p21激活激酶4抗體
xy-3717R    Phospho-p73(Tyr99)磷酸化P73腫瘤抑制基因抗體
xy-3718R    Phospho-p95 NBS1 (Ser343)磷酸化DNA修復(fù)蛋白NBS1抗體
xy-1573R    PUMAp53正向細(xì)胞凋亡調(diào)控因子抗體
xy-4151R    PLDL1磷脂酶C1樣蛋白抗體
xy-6742R    Prostate and colon associated protein前列腺癌和結(jié)腸癌相關(guān)蛋白
xy-0361R    Protein G重組蛋白G抗體
xy-2067R    PIK3CA磷脂酰肌醇激酶催化亞單位A抗體
xy-1476R    PDI蛋白質(zhì)二硫鍵異構(gòu)酶抗體